Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individualized Management of Pancreatic Cancer With Targeted Therapeutics (IMPACTT): A Phase II Clinical Trial

NCT00429858 is registered in ClinicalTrials.gov with Andrew Ko as lead sponsor.

NCT NCT00429858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00429858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individualized Management of Pancreatic Cancer With Targeted Therapeutics (IMPACTT): A Phase II Clinical Trial
Lead sponsor
Andrew Ko
Phase
Phase 2
Overall status
Terminated
Start date
January 22, 2007
Completion date
January 20, 2010
Enrollment
21 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer